CCL5 and IL17 are also expressed in several solid and hematological malignancies, influencing ECM (extracellular matrix) remodeling and migration, cancer stem cell expansion, DNA damage repair, metabolic reprogramming, and angiogenesis [24,25]. The gene discussed is CCL5; the disease is hematologic disorder.